Gerald A Riley CADCIII
Counselor/Therapist | Addiction (Substance Use Disorder)
2010 NW LOGAN ST TOPEKA KS, 66608About
Gerald Riley is an Addiction Medicine Counselor in TOPEKA, KS. Gerald evaluates patients using many different procedures, in order to determine what treatments must be carried out in order to properly assess their symptoms. Addiction Medicine counselors provide patient care and consultation for each patient and their families.
Provider Details
Gerald A Riley CADCIII's Practice location
Gerald A Riley CADCIII's reviews
Write ReviewRecommended Articles
- 10 Tips For Dealing With Fibro Fog
Although the major symptoms of fibromyalgia are widespread pain and chronic fatigue, many individuals report a feeling of confusion and forgetfulness. This feeling is often referred to as the “fibro fog”. The cause of these cognitive difficulties is unknown, but may be attributable to the sleep...
- Celiac Disease Patients No Longer Considered High-Risk for Cancer
How celiac disease can affect the bodyThere have been numerous studies that were conducted to show the effects that celiac disease might or might not have in relation to the body. This particular one has looked into patients for a span of ten years, measuring how different conditions developed...
- How Prevalent Is Affluenza?
IntroductionInfluenza and affluence combine to form the word affluenza. Similar to how viruses infect their host, affluenza, being a social virus, infects millions of people around the world. It consumes the lives of people with the bold pursuit of materialism. It is predominantly an American...
- Bright-Light Treatment for Fibromyalgia: Is It Effective?
Fibromyalgia is a chronic disease that causes widespread pain accompanied by general fatigue, sleep, and memory problems. While the cause of fibromyalgia is unknown, studies have shown that abnormal levels of certain chemicals in the central nervous system triggered by the combination of genetic and...
- New Cystic Fibrosis Treatment Shows Promise for those with a Specific Gene Mutation
The data released on July 18th from three clinical trials conducted by Vertex Pharmaceuticals revealed promising results. The drugs that were tested in these trials are three different triple combination regimes that are designed to treat the underlying cause of cystic fibrosis in patients with the...